Internal Server Error

List of Horizon Therapeutics's Acquisitions

lockFilter this list
Horizon Therapeutics has made a total of 5 acquisitions. These activities spanned 5 sectors, including Rare Diseases, Immunology, Genomics, and two others, across United States and Switzerland. Peak acquisition years were 2015, 2016, and 2020, with 1 acquisition each. The average number of acquisitions per year from 2020 to 2025 is 0.2, and there have been 0 acquisitions this year. The most recent acquisition was Viela Bio, founded in 2017 in Gaithersburg, which develops biologics for severe inflammation and autoimmune diseases. This transaction was completed in December 2020.

Here's the year on year acquisition history of Horizon Therapeutics:

Year on year acquisition history of Horizon Therapeutics2020Acquisitions Round Date (Yearly)012
  • Number of Total Acquisitions
Year
# Acquisitions
2020
1
2016
1
2015
1
2014
1
2010
1

Recent acquisitions by Horizon Therapeutics

Horizon Therapeutics's most recent acquisition - Viela Bio is a Developer of biologics for treating severe inflammation and autoimmune diseases, founded in 2017 and located in Gaithersburg. Horizon Therapeutics acquired it in December 2020 for a price of $*****.

Here is the list of all acquisitions by Horizon Therapeutics sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Dec 31, 2020
agle
nmsb
54
184
Sep 12, 2016
obbx
bnwg
46
295
Dec 11, 2015
jftg
z{wc
45
587

View the full list of acquisitions

Sign Up for Free

FAQs about Acquisitions by Horizon Therapeutics

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford